- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
IBB
Trade of the Day: Celgene Corporation Attempts a Breakout
CELG stock for the first time in a couple of months is showing a more promising near-term buy signal. Celgene's reward to risk is promising.
Go Long Mylan N.V. After Earnings With Confidence
Biotech companies are still under threat from the White House. So I sell risk in Mylan for income into those fears. Bet on MYL stock support for cash.
Buy Allergan Plc Ordinary Shares After the Earnings!
After a long stint of selling, AGN stock is finally showing signs of stabilization. I want to generate income from Allergan support.
Pfizer Inc. Stock Is Boring, and That’s Perfect
Pfizer has been a boring stock for years. Which makes PFE stock perfect to sell downside risk against unlikely scenarios.
Buy the Dip in Amgen, Inc. While Wall Street Fears It
Biotech falling knives like Amgen are notoriously dangerous, but AMGN stock has value against which I am willing to bet bullish.
Trade of the Day: Amgen, Inc. Nears a Buy Point Again
This latest pullback in AMGN stock now looks to provide a better reward-to-risk opportunity to buy Amgen again.
Catch This Falling Knife — Go Long Celgene Corporation
Pharma stock falling knives are the scariest to catch. But this reaction to the Celgene headline is overdone. Catch CELG but with caution.
Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow
Momentum rallies are often a show of good support. Bet on Pfizer (PFE ) stock's proven levels to hold for at least six months.
Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
Trade of the Day: Amgen, Inc. (AMGN) Stock Has Plenty More Upside
AMGN stock is higher by just about 27% for the year-to-date, but in the bigger picture Amgen really just started on a new breakout rally.
Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
Profit From the Biogen Inc (BIIB) Stock Dip!
Momentum stocks especially in the biotech industry are daunting knives to catch. Make it easier by selling puts for income with a big buffer.
Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear
BMY is rallying on solid fundamentals to reclaim a long-term pivot levels as support for even higher prices. Go long on strong support.
Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock
Wall Street goes on buying sprees into the biotech sector. Take advantage of this run to profit from red hot AMGN Stock. It's headed higher.
The Move in SPDR S&P Biotech (ETF) (XBI) ETF Is Coming — Get on Board
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
Respect the Choppy Stock Market
Volatility remains eerily low, but as a former mentor used to remind me, one can learn much by just watching and being prepared.
